Lensar, Inc. (LNSR) — 8-K Filings
All 8-K filings from Lensar, Inc.. Browse 12 Current Event Report reports with AI-powered summaries and risk analysis.
8-K Filings (12)
-
LENSAR, Inc. Files 8-K for Q1 2026 Financials
— Mar 31, 2026 Risk: low
LENSAR, Inc. filed an 8-K on March 31, 2026, reporting its financial results and condition for the period ending March 31, 2026. The filing includes financial s - 8-K Filing — Dec 19, 2025
-
LENSAR, Inc. Files 8-K on Shareholder Nominations
— Oct 21, 2025 Risk: medium
LENSAR, Inc. filed an 8-K on October 21, 2025, reporting shareholder nominations pursuant to Exchange Act Rule 14a-11 and other events. The report covers activi -
LENSAR, Inc. Files 8-K on Financials
— Aug 7, 2025 Risk: low
LENSAR, Inc. filed an 8-K on August 7, 2025, reporting on its Results of Operations and Financial Condition. The filing includes financial statements and exhibi -
LENSAR, Inc. Reports on Security Holder Vote
— Jul 2, 2025 Risk: low
LENSAR, Inc. filed an 8-K on July 2, 2025, reporting on a submission of matters to a vote of security holders. The filing does not contain specific details abou -
LENSAR, Inc. Files 8-K Report
— May 22, 2025 Risk: low
On May 21, 2025, LENSAR, Inc. filed an 8-K report. The filing indicates "Other Events" as the primary item of disclosure. No specific financial transactions or -
LENSAR, Inc. Files 8-K: Material Agreement, FD Disclosure
— Mar 24, 2025 Risk: medium
On March 23, 2025, LENSAR, Inc. entered into a Material Definitive Agreement. The filing also includes a Regulation FD Disclosure and other events, along with f -
LENSAR, Inc. Files 8-K on Security Holder Vote
— May 13, 2024 Risk: low
On May 7, 2024, LENSAR, Inc. filed an 8-K report detailing the submission of matters to a vote of its security holders. The filing does not specify the nature o -
LENSAR, Inc. Files 8-K on Financials
— May 9, 2024 Risk: low
On May 9, 2024, LENSAR, Inc. filed an 8-K report. The filing primarily concerns the company's financial condition and results of operations, along with financia -
LENSAR Appoints New CMO, Director; Updates Officer Compensation
— May 8, 2024 Risk: low
On May 3, 2024, LENSAR, Inc. announced the appointment of Dr. Jeffrey Spragens as Chief Medical Officer and the election of Ms. Laura L. E. Smith to its Board o -
LENSAR Reports Executive Changes and Compensation Arrangements
— Feb 26, 2024 Risk: medium
LENSAR, Inc. filed an 8-K on February 26, 2024, reporting events that occurred on February 20, 2024. The filing pertains to changes in the company's leadership, -
LENSAR 8-K: Executive Compensation Arrangements Updated
— Feb 6, 2024
LENSAR, Inc. filed an 8-K on February 6, 2024, reporting events that occurred on January 31, 2024, related to changes in its executive compensation arrangements
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX